Du Pont to sell in vitro diagnostics unit
Du Pont has agreed to sell its in vitro diagnostics business toDade International of Deerfield, IL. The unit manufactures andsells products for clinical chemistry and immunodiagnostic testingand had 1994 sales of $326 million, according to Du Pont, of
Du Pont has agreed to sell its in vitro diagnostics business toDade International of Deerfield, IL. The unit manufactures andsells products for clinical chemistry and immunodiagnostic testingand had 1994 sales of $326 million, according to Du Pont, of Wilmington,DE.
The sale is part of Du Pont's plan to divest its Medical Productsbusinesses in order to pay for the repurchase of stock from Seagram(SCAN 6/7/95). The sale does not involve Du Pont's medical imagingfilm and PACS operations, however. Du Pont expects to announcea buyer for those businesses in the next four to six weeks.
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.
